Rna interference mediated inhibition of type 1 insulin-like growth factor receptor (igf-1r)

阅读量:

25

申请(专利)号:

WO2003US05044

申请日期:

2003-02-20

公开/公告号:

WO03070911A2

公开/公告日期:

2003-08-28

申请(专利权)人:

RIBOZYME PHARMACEUTICALS, INC;MCSWIGGEN, JAMES;BEIGELMAN, LEONID;CHOWRIRA, BHARAT

发明人:

LEONID BEIGELMANJAMES MCSWIGGENBHARAT CHOWRIRA

展开

被引量:

17

摘要:

The present invention concerns methods and reagents useful in modulating gene expression in a variety of applications, including use in therapeutic, diagnostic, target validation, and genomic discovery applications. Specifically, the invention relates to synthetic chemically modified small nucleic acid molecules, such as short interfering nucleic acid (siNA), short interfering RNA (siRNA), double-stranded RNA (dsRNA), micro-RNA (miRNA), and short hairpin RNA (shRNA) molecules capable of mediating RNA interference (RNAi) against target nucleic acid sequences. The small nucleic acid molecules are useful in the treatment of any disease or condition that responds to modulation of gene expression or activity in a cell, tissue, or organism.

展开

通过文献互助平台发起求助,成功后即可免费获取论文全文。

相似文献

参考文献

引证文献

引用走势

2012
被引量:5

辅助模式

0

引用

文献可以批量引用啦~
欢迎点我试用!

关于我们

百度学术集成海量学术资源,融合人工智能、深度学习、大数据分析等技术,为科研工作者提供全面快捷的学术服务。在这里我们保持学习的态度,不忘初心,砥砺前行。
了解更多>>

友情链接

百度云百度翻译

联系我们

合作与服务

期刊合作 图书馆合作 下载产品手册

©2025 Baidu 百度学术声明 使用百度前必读

引用